Article Menu
Need Help?
No Article Versions Notes Found
Cite
Quirbt, I.; Verma, S.; Petrella, T.; Bak, K.; Charette, M.; , the members of the Melanoma Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care. Temozolomide for the Treatment of Metastatic Melanoma. Curr. Oncol. 2007, 14, 27-33. https://doi.org/10.3747/co.2007.98
Quirbt I, Verma S, Petrella T, Bak K, Charette M, the members of the Melanoma Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care. Temozolomide for the Treatment of Metastatic Melanoma. Current Oncology. 2007; 14(1):27-33. https://doi.org/10.3747/co.2007.98
Chicago/Turabian StyleQuirbt, I., S. Verma, T. Petrella, K. Bak, M. Charette, and the members of the Melanoma Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care. 2007. "Temozolomide for the Treatment of Metastatic Melanoma" Current Oncology 14, no. 1: 27-33. https://doi.org/10.3747/co.2007.98
APA StyleQuirbt, I., Verma, S., Petrella, T., Bak, K., Charette, M., & , the members of the Melanoma Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care. (2007). Temozolomide for the Treatment of Metastatic Melanoma. Current Oncology, 14(1), 27-33. https://doi.org/10.3747/co.2007.98
